The overall goal of the Genetics and Genomics (GG) Program is to discover novel cancer genes, to elucidate the function of diverse genetic and epigenetic states, to translate mechanistic insight into therapeutic targets and associated biomarkers, and to accelerate the delivery of precision cancer medicine to our patients. This will be accomplished in three aims:
Aim 1 ? To interrogate genetic drivers of tumor hallmarks;
Aim 2 ? To delineate epigenetic states as biomarkers and targets in cancer, and Aim 3 ? To translate of genetic and epigenetic discovery toward clinical application. A number of important scientific discoveries emanated from the GG Program that illustrate the overall research depth, cancer focus, and added value. Additionally, the GG Program developed unique tumor sequencing data and analysis approaches to support precision medicine concepts. For example, panels developed within the GG Program were leveraged toward the development of a molecular diagnostic company (OmniSeq) that contributes to the recruitment of Roswell Park patients into molecular basket trials, such as NCI-MATCH. The GG Program research portfolio encompasses studies addressing genetic basis of aggressiveness of hormone refractory breast and prostate cancer in African- American populations ? cancers that are of particular importance for our WNY catchment area. John Krolewski, MD, PhD and Erik Knudsen, PhD are new co-Leaders for the Program who have strong interests in basic, clinical, and population aspects of tumor genetics and epigenetics. Dr. Krolewski's leadership efforts focus on signaling/cytokine pathways and genomics of genitourinary malignancies, which complements Dr. Knudsen's focus in the areas of cell cycle control and genomic stability, and targeting such pathways in breast and gastrointestinal cancers. The Program is comprised of 27 members from nine Roswell Park departments/centers (Cancer Genetics and Genomics, Center for Personalized Medicine, Molecular and Cellular Biology, Pharmacology and Therapeutics, Urology, Thoracic Surgery, Biostatistics and Bioinformatics, Medicine, and Pathology), whose total peer-reviewed funding is $3.1M direct costs (NCI funding $1.9M direct) and a total funding of $5.4M direct costs. Since the last renewal, 12 new members (nine recruited from outside Roswell Park) have joined the Program. Of the 385 publications generated over the last funding cycle, 9% are intra-programmatic and 44% are inter-programmatic; 50 (13%) publications are in journals with an impact factor >10. Future goals of the Program are focused on multi-investigator projects that make impactful discoveries and translate basic science into the clinical arena, harnessing GG science to target cancers at the genetic and epigenetic levels.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Roswell Park Cancer Institute Corp
United States
Zip Code
Liu, Chunhong; Yu, Tao; Xing, Zhuo et al. (2018) Triplications of human chromosome 21 orthologous regions in mice result in expansion of megakaryocyte-erythroid progenitors and reduction of granulocyte-macrophage progenitors. Oncotarget 9:4773-4786
Muramatsu, Masashi; Akakura, Shin; Gao, Lingqiu et al. (2018) SSeCKS/Akap12 suppresses metastatic melanoma lung colonization by attenuating Src-mediated pre-metastatic niche crosstalk. Oncotarget 9:33515-33527
Kumar, Sandeep; Inigo, Joseph R; Kumar, Rahul et al. (2018) Nimbolide reduces CD44 positive cell population and induces mitochondrial apoptosis in pancreatic cancer cells. Cancer Lett 413:82-93
Shenoy, Gautam N; Loyall, Jenni; Maguire, Orla et al. (2018) Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses. Cancer Immunol Res 6:236-247
Cimato, Thomas R; Conway, Alexis; Nichols, Julianne et al. (2018) CD133 expression in circulating hematopoietic progenitor cells. Cytometry B Clin Cytom :
Gurova, Katerina; Chang, Han-Wen; Valieva, Maria E et al. (2018) Structure and function of the histone chaperone FACT - Resolving FACTual issues. Biochim Biophys Acta Gene Regul Mech :
Soh, Kah Teong; Wallace, Paul K (2018) RNA Flow Cytometry Using the Branched DNA Technique. Methods Mol Biol 1678:49-77
Ramakrishnan, Swathi; Huss, Wendy; Foster, Barbara et al. (2018) Transcriptional changes associated with in vivo growth of muscle-invasive bladder cancer cell lines in nude mice. Am J Clin Exp Urol 6:138-148
Chang, Han-Wen; Valieva, Maria E; Safina, Alfiya et al. (2018) Mechanism of FACT removal from transcribed genes by anticancer drugs curaxins. Sci Adv 4:eaav2131
Dong, Jing; Buas, Matthew F; Gharahkhani, Puya et al. (2018) Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology 154:1273-1281.e3

Showing the most recent 10 out of 1555 publications